GleamWall
中文EN

CAPR CAPRICOR THERAPEUTICS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1133869 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (2024Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-11.5%
TTM net income YoY-81.6%
TTM EPS YoY-38.6%
Revenue 3-yr CAGR349.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-191.1%
Net margin-181.7%
FCF margin-184.8%
EBITDA margin-184.7%

Returns

ROE-48.2%
ROA-35.3%
ROIC (approx.)-47.3%
Asset turnover0.19x

Leverage & solvency

Liabilities / assets14.7%
Debt / equity0.00x
Current ratio7.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.99x
Accruals ratio-0.4%
Payout ratio—
Capex / revenue5.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$22.27M
R&D expense$84.45M$49.97M
SG&A expense$23.69M$14.87M
Operating income-$108.14M-$42.56M
Interest expense$3.05M$0
Pretax income-$105.04M-$40.47M
Income tax$1,600$1,600
Net income-$105.04M-$40.47M
EBITDA-$106.25M-$41.14M
EPS (basic)-2.26-1.15
EPS (diluted)-2.26-1.15
Weighted avg. shares (diluted)46.48M35.22M
Balance sheet
Cash & equivalents$287.85M$11.29M
Short-term investments$30.28M$140.23M
Current assets$322.94M$163.39M
PP&E, net$18.31M$5.56M
Total assets$355.95M$170.48M
Current liabilities$35.84M$21.03M
Total liabilities$50.16M$25.02M
Shareholders' equity$305.79M$145.46M
Shares outstanding57.37M45.58M
Cash flow statement
Operating cash flow-$69.81M-$40.00M
Capital expenditure$2.90M$1.17M
Free cash flow-$72.72M-$41.16M
Investing cash flow$97.48M-$116.18M
Financing cash flow$248.89M$152.77M
Depreciation & amortization$1.89M$1.43M
Stock-based compensation$17.23M$9.77M

Free plan shows the latest 2 periods; Pro shows all 20 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.